T-Y Zhou

Value of Serum Galectin 3 in Patients with Hepatocellular Carcinoma: A Meta-Analysis

Issue:

Vol 71, Issue 1: 2024

DOI:

10.7727/wimj.2016.532

Pages:

14-8

Synopsis:

Serum Galectin 3 is a promising diagnostic indicator for some carcinomas. This study estimated the serum Gal-3 in patients with hepatocelluar carcinoma and showed that the expression of serum Galectin 3 tended to be a bigger biomarker for diagnosis of Hepatocellular carcinoma (HCC).

ABSTRACT

Objective: To investigate the connection of Galectin 3 with hepatocellular carcinoma (HCC) risk.

Methods: Publications were searched using PubMed, MEDLINE, EMBASE and the Chinese databases (including CNKI and WanFang) up to October 2015.

Received:

27 Oct, 2016

Revised:

03 Jan, 2017

Published:

30 Mar, 2024

PDF Attachment: